ClinicalTrials.Veeva

Menu

Turkish Translation of The Emphasis-10 Questionnaire

I

Istanbul University

Status

Completed

Conditions

Pulmonary Hypertension

Treatments

Other: Quality of Life

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Pulmonary Hypertension (PH) is a hemodynamic and physiopathological condition that is defined as an increase in mean pulmonary artery pressure ≥25 mmHg when measured at rest. PH often progresses to heart failure and premature deaths. PH is a progressive disease that has many causes, which can affect people of all ages, is characterized by shortness of breath, reduced exercise tolerance, psychological distress and tiredness and reduced quality of life. Surveys of SF-36, 'Nottingham Health Profiles' and 'Minnesota Life with Heart Failure' surveys are routinely performed in PH clinically. However, none of the questionnaires are specific to pulmonary hypertension, so they are incomplete in determining the condition of the disease and the patients. There is no Turkish questionnaire for patients with pulmonary hypertension and other surveys used are inadequate in determining the condition of the patient and the patient since they are not specific to the disease. The aim is to provide a Turkish questionnaire that is specific to pulmonary hypertension in the literature.

Enrollment

101 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have been diagnosed with Pulmonary Hypertension
  • Following at least 6 months of Pulmonary Hypertension policlinic
  • Native Turkish
  • People age 18 years or older

Exclusion criteria

  • Those with cognitive impairment
  • Those who have difficulty understanding or speaking Turkish

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems